Replies to post #99587 on Biotech Values

[turtlepower]

I must have missed the posts addressing the legal challenges m-enox will face. are these potential challenges even a credible threat? Surely a judge can't have more scientific credibility than the FDA. IMO if enthusiasm is muted it will be because of the potential of Teva's application being approved followed by SNY launching an AG and then competition from other anticoagulents like rivaroxaban and apixaban.